share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Oct 2 16:36

Summary by Moomoo AI

Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more